DiscoverX

Birmingham, United Kingdom Founded: 2000 • Age: 26 yrs Acquired By Eurofins Scientific
Develops cell-based assays and provides services for drug discovery and development.

About DiscoverX

DiscoverX is a Healthcare company based in Birmingham (United Kingdom) founded in 2000, and was acquired by Eurofins Scientific in July 2017. It develops cell-based assays and provides services for drug discovery and development. DiscoverX has raised $13.4 million across 3 funding rounds from investors including Eurofins Scientific. DiscoverX has completed 1 acquisition, including BioSeek. Its website discoverx.com draws about 20 thousand monthly visits. DiscoverX offers products and services including Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is DISCOVERX CORPORATION, LTD.

Company details

Reagent and complete cell-based assay kits are developed, manufactured, and marketed by DiscoverX, along with profiling and screening services for drug discovery. The BioMAP platform, which simulates human cell types and tissue interactions in disease states, is utilized to support screening, lead optimization, and SAR campaigns. Founded in 2000, operations are based in the biotechnology sector in Birmingham, United Kingdom.

  • Headquarters Birmingham, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website discoverx.com
  • Social LinkedIn X YouTube
  • Acquired by Eurofins Scientific (Jul 2017)
  • Legal Name Discoverx Corporation, Ltd.
Key Metrics

Products & Services of DiscoverX

DiscoverX offers a comprehensive portfolio of products and services, including Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays.

Bioassay Kits
Drug Development Tools

Kits for accelerating development of obesity and diabetes drugs.

Recombinant Helicases
Biotech Products

Proteins for hit finding and therapeutic innovation in DNA and RNA.

Checkpoint Agonist Antibody Assays
Immunotherapy Tools

Assays to detect potential in antibody candidates for checkpoint receptors.

Apps and channels of DiscoverX

its YouTube channel Eurofins DiscoverX has 1.4K subscribers and 30 videos.

Eurofins DiscoverX
YouTube 1.4K subscribers 30 videos Science & Technology
Open channel

Videos from DiscoverX

The most watched videos on DiscoverX's YouTube channel, Eurofins DiscoverX (1.4K subscribers). Click a video to play it here.

Detection of Protein Turnover Induced by Targeted Degraders
207.8K views
Eurofins DiscoverX Pharmacotrafficking Assay
47.6K views
Eurofins DiscoverX GPCR Assays
34.8K views
Eurofins DiscoverX Internalization Assays
3K views

More on Eurofins DiscoverX.

Funding Insights of DiscoverX

DiscoverX has successfully raised a total of $13.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $8 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $13.4M
  • Total Rounds 3
  • Last Round Series B β€” $8M

All 3 funding rounds of DiscoverX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2010$8MSeries B––
–
Aug 2009$5.4MSeries A––
–
Mar 2007Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in DiscoverX

DiscoverX has secured backing from 1 investor. Prominent investors backing the company include Eurofins Scientific.

All
InvestorDescriptionFounded YearDomainLocation
Laboratory testing and contract research services are provided globally.
1987eurofins.comLuxembourg, Luxembourg
Premium access

Investor details for DiscoverX

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DiscoverX

20 people are tracked at DiscoverX (6 in leadership, 14 in team).

NameRoleGroup
Gilles G. Martin
CEOLeadership
Dana Haley-Vicente
Associate Director Of MarketingLeadership
Gaurav Agrawal
Director Of Market Development And Scientific ApplicationsLeadership
Alpana Prasad
Director Of Product ManagementLeadership
Jagdish Saini
VP Of OperationsLeadership
Neil Charter
Senior DirectorLeadership
Stephanie Fong
Associate Project ManagerTeam
Arvind Kannan
Senior Marketing ManagerTeam
Nisha Shankaran
Program ManagerTeam
Venkatesh Chari
Market Development ManagerTeam
Christopher Frank (He, Him, His)
Client Services Representative Lll - Project ManagerTeam
Poonam Kaul
Product Manager For In Vitro Pharmacology ServicesTeam
Tsung-Chin Lin
Senior Manager, Tech Transfer, Cell Manufacturing And QC Process DevelopmentTeam
James Costantin
Scientific Market Development Manager - Ion ChannelsTeam
Shruti K.
Field Application ScientistTeam
Em Bacon
Client Services RepresentativeTeam
Nicole Servant
Business Uni Manager: Leadhunter ServicesTeam
Nikki Smith-Nguyen
Office ManagerTeam
Rachael Littlewood
Shipping AdministratorTeam
Divya Premkumar
Project Manager IITeam
Premium access

Complete people profiles for DiscoverX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DiscoverX

DiscoverX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioSeek.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of drug discovery services
bioseekinc.comSan Francisco, United States2000Oct 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for DiscoverX

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of DiscoverX

5 dated milestones of DiscoverX across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded DiscoverX is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B, of $8.0M.
  4. Acquisition Acquires BioSeek.
  5. Exit Acquired by Eurofins Scientific.

Web traffic of DiscoverX

The website of DiscoverX (discoverx.com) receives about 20K visits a month.

  • Monthly visits
    20K

    ▼ 51.4% vs previous month

Similar websites

Websites whose visitors overlap most with DiscoverX. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ebiohippo.com
ebiohippo.com
100%
#1,393,194–
abeomics.com
94%
#3,028,425View details
genego.com
94%
View details
scrb.harvard.edu
scrb.harvard.edu
94%
–
molgen.mpg.de
molgen.mpg.de
94%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 33 similar websites and full traffic analytics for DiscoverX

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 33 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as DiscoverX (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Discoverx

Premium access

Complete news archive for DiscoverX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DiscoverX

DiscoverX was founded in 2000 and raised its 1st funding round 7 years after it was founded.

DiscoverX is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.

DiscoverX is a funded company, having raised a total of $13.4M across 3 funding rounds to date.

Reagent and complete cell-based assay kits are developed, manufactured, and marketed by DiscoverX, along with profiling and screening services for drug discovery. The BioMAP platform, which simulates human cell types and tissue interactions in disease states, is utilized to support screening, lead optimization, and SAR campaigns. Founded in 2000, operations are based in the biotechnology sector in Birmingham, United Kingdom.

DiscoverX offers Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays.

DiscoverX has made 1 acquisition, including BioSeek.

DiscoverX has 1 investor. Key investors include Eurofins Scientific.

DiscoverX operates through Discoverx Corporation, Ltd..

Yes. DiscoverX was acquired by Eurofins Scientific in July 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available